Evogene Stock Price, News & Analysis (TSE:EVGN) Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetC$5.92 About Evogene Stock (TSE:EVGN)Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.Read More EVGN Stock News HeadlinesNovember 29, 2023 | finance.yahoo.comBears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' NowNovember 14, 2023 | msn.comEvogene Q3 2023 Earnings PreviewDecember 6, 2023 | Financial Alphas (Ad)Countries Are Investing Heavily Into Securing Energy IndependenceThere's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.October 18, 2023 | finance.yahoo.comEvogene Provides Operational Update Amidst Current Security Situation in IsraelOctober 14, 2023 | investing.comEvergreen Fibreboard Bhd (EVGN)October 10, 2023 | finanznachrichten.deEVOGENE LTDOctober 3, 2023 | msn.comAlliance Global Partners Initiates Coverage of Evogene (EVGN) with Buy RecommendationSeptember 27, 2023 | finance.yahoo.comCasterra Delivers First Shipment of Castor Seeds to AfricaDecember 6, 2023 | Financial Alphas (Ad)Countries Are Investing Heavily Into Securing Energy IndependenceThere's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.September 21, 2023 | benzinga.comWhy Evogene Shares Are MovingAugust 19, 2023 | msn.comLake Street Maintains Evogene (EVGN) Buy RecommendationAugust 2, 2023 | msn.comEvogene (EVGN) Price Target Increased by 166.67% to 4.08July 19, 2023 | finance.yahoo.comBiomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) ProgramJuly 17, 2023 | marketwatch.comEvogene Shares Tumble Amid Planned Stock Sale >EVGNJuly 17, 2023 | marketwatch.comEvogene Unit in Bio-Fungicides License Pact With Corteva >EVGNJuly 17, 2023 | technews.tmcnet.comEvogene Announces Pricing of US$8,500,000 Registered Direct OfferingJuly 3, 2023 | msn.comEvogene up 8%, Casterra subsidiary gets $2.2M order for castor seedsJune 21, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS) and Evogene (EVGN)June 21, 2023 | msn.comEvogene unit Casterra signs castor seed supply deal for biofuel productionJune 21, 2023 | msn.comEvogene subsidiary nabs $9.1m deal for supply of castor seeds for biofuel productionJune 21, 2023 | msn.comWhy Evogene (EVGN) Stock Is Trading HigherMay 17, 2023 | msn.comEvogene Q1 2023 Earnings PreviewMay 17, 2023 | markets.businessinsider.comEvogene is about to announce its earnings — here's what to expectMay 9, 2023 | technews.tmcnet.comEvogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation and Drought ToleranceMay 2, 2023 | msn.comLake Street Initiates Coverage of Evogene (EVGN) with Buy RecommendationMay 2, 2023 | finance.yahoo.comPlantis Licenses Two of Canonic's Proprietary Cannabis Varieties to Expand its Offerings in the Israeli MarketApril 28, 2023 | benzinga.comEvogene Stock (NASDAQ:EVGN), Short Interest ReportSee More Headlines Receive EVGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE Industry Pesticide & Other Agricultural Chemical Manufacturing Sub-IndustryN/A SectorManufacturing Current SymbolTSE:EVGN CUSIPN/A CIKN/A Webwww.evogene.com PhoneN/AFaxN/AEmployees131Year FoundedN/APrice Target and Rating Average Stock Price TargetC$5.92 High Stock Price TargetC$7.50 Low Stock Price TargetC$4.25 Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key Competitors(EDW.V)CVE:EDW(FSN.V)CVE:FSN(FTE.V)CVE:FTE(PDH)CNSX:PDH108946 (AUA.V)CVE:AUAView All Competitors EVGN Stock Analysis - Frequently Asked Questions Should I buy or sell Evogene stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evogene in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" EVGN shares. View EVGN analyst ratings or view top-rated stocks. What is Evogene's stock price target for 2024? 2 Wall Street research analysts have issued 1 year price targets for Evogene's shares. Their EVGN share price targets range from C$4.25 to C$7.50. On average, they expect the company's share price to reach C$5.92 in the next twelve months. View analysts price targets for EVGN or view top-rated stocks among Wall Street analysts. How do I buy shares of Evogene? Shares of EVGN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:EVGN) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.